144 ·Filed May 4, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001950047-26-004013
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

The 10b5-1 plan indicates pre-scheduled sales; no new bearish signal. Monitor for any acceleration or deviation from the pattern, but the filing itself is routine. The stock's consensus is 77% bullish, suggesting limited downside from insider activity alone.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
UTHR ▼ -8.14% at T+60d
NEUTRAL call ✗ call lost -8.14% · α vs SPY -10.62% · entry $572.42 → $525.82
Entry anchored
May 4, 2026
via day open
T+1d
+3.74%
call +3.74% · α +2.36%
$593.84
settled 5mo ago
T+5d
+1.15%
call +1.15% · α -0.84%
$578.99
settled 5mo ago
T+20d
-5.66%
call -5.66% · α -10.61%
$540.05
settled 4mo ago
T+60d
-8.14%
call -8.14% · α -10.62%
$525.82
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Officer James Edgemond files Form 144 to sell 148,750 shares ($84.8M) from option exercises under a pre-arranged 10b5-1 plan. The filing continues a systematic weekly selling pattern since March 2026, indicating routine portfolio diversification rather than a change in outlook.

Key Facts

  • Officer James Edgemond intends to sell 148,750 shares valued at ~$84.8 million.
  • Shares to be sold are from exercise of stock options under a 10b5-1 plan.
  • Prior 10b5-1 sales of 10,000 shares each occurred on 12 dates from March 30 to April 30, 2026.
  • The filing represents ~0.35% of UTHR's $24.2B market cap.

Financial Impact

$84.8 million from sale of 148,750 shares

dilution

Risk Factors

  • Large insider sales could pressure stock if market interprets as lack of confidence, but 10b5-1 plan mitigates this.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-004013
Document: 0001950047-26-004013-index.html0001950047-26-004013
Document: 0001950047-26-004013.txt0001950047-26-004013
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$573.51 (+14.62%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$573.51 (+15.37%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$573.51 (+13.82%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$573.51 (+13.16%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$573.51 (+17.62%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$573.51 (+17.48%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$573.51 (+11.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$573.51 (+8.64%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$573.51 (+11.00%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access